pemigatinib
Showing 1 - 25 of 29
Solid Tumor, FGF Receptor Gene Mutation, FGF Amplification Trial in Tianjin (Pemigatinib)
Recruiting
- Solid Tumor
- +4 more
- Pemigatinib
-
Tianjin, Tianjin, ChinaTianjin Medical University Second Hospital
Aug 28, 2023
Carcinoma, Intrahepatic Cholangiocarcinoma, Digestive System Tumors Trial in Guangzhou (Pemigatinib, PD-1 Inhibitors)
Recruiting
- Carcinoma
- +4 more
- Pemigatinib
- PD-1 Inhibitors
-
Guangzhou, Guangdong, ChinaLei Zhang
Jun 21, 2023
Gastrointestinal Cancer Trial in Tianjin (Pemigatinib)
Recruiting
- Gastrointestinal Cancer
- Pemigatinib
-
Tianjin, Tianjin, ChinaTianjin Medical University Cancer Institute & Hospital
Dec 7, 2022
Advanced Intrahepatic Cholangiocarcinoma Trial (Pemigatinib)
Not yet recruiting
- Advanced Intrahepatic Cholangiocarcinoma
- Pemigatinib
- (no location specified)
Sep 30, 2022
Cholangiocarcinoma Trial in Shanghai (Pemigatinib)
Active, not recruiting
- Cholangiocarcinoma
- Pemigatinib
-
Shanghai, Shanghai, ChinaZhongshan Hospital Affiliated to Fudan University
Oct 3, 2022
Breast Cancer Trial in Tianjin (Pemigatinib Pill)
Recruiting
- Breast Cancer
- Pemigatinib Pill
-
Tianjin, Tianjin, ChinaBreast Oncology, Tianjin Medical University Cancer Institute and
Sep 26, 2022
Gastrointestinal Cancer Trial in Hangzhou (Pemigatinib Pill)
Recruiting
- Gastrointestinal Cancer
- Pemigatinib Pill
-
Hangzhou, Zhejiang, ChinaZhejiang Cancer Hospital
Sep 26, 2022
NSCLC Trial in Suzhou (Pemigatinib)
Recruiting
- Non-Small Cell Lung Cancer
- Pemigatinib
-
Suzhou, ChinaThe First Affiliated Hospital of Soochow University
Jan 14, 2022
FGFR1 Gene Amplification, FGFR1 Gene Mutation, FGFR1 Gene Translocation Trial in United States (Pemigatinib, Quality-of-Life
Active, not recruiting
- FGFR1 Gene Amplification
- +18 more
- Pemigatinib
- Quality-of-Life Assessment
-
Scottsdale, Arizona
- +5 more
Oct 18, 2022
Advanced NSCLC Trial in Xiamen (Pemigatinib)
Recruiting
- Advanced Non-Small Cell Lung Cancer
- Pemigatinib
-
Xiamen, Fujian, Chinathe First Affiliated Hospital of Xiamen University
Mar 10, 2022
Urothelial Cancer Trial in Italy (Pemigatinib)
Active, not recruiting
- Urothelial Cancer
- Pemigatinib
-
Bergamo, Italy
- +4 more
Jan 25, 2022
Advanced Malignancies Trial in Worldwide (Pemigatinib, Retifanlimab, Pembrolizumab)
Recruiting
- Advanced Malignancies
- Pemigatinib
- +2 more
-
Santa Monica, California
- +6 more
Apr 6, 2022
Gastric and Colorectal Cancer Trial in Wuhan (pemigatinib)
Recruiting
- Gastric and Colorectal Cancer
- pemigatinib
-
Wuhan, Hubei, ChinaCancer Center, Union Hospital, Tongji Medical College, Huazhong
Jan 9, 2022
Advanced Cholangiocarcinoma, Metastatic Cholangiocarcinoma, Unresectable Cholangiocarcinoma Trial in United States (Cisplatin,
Recruiting
- Advanced Cholangiocarcinoma
- +2 more
- Cisplatin
- +3 more
-
Scottsdale, Arizona
- +7 more
Jun 24, 2022
Locally Advanced Unresectable Gastric Cancer Trial in Guangzhou (Pemigatinib)
Not yet recruiting
- Locally Advanced Unresectable Gastric Cancer
- Pemigatinib
-
Guangzhou, Guangdong, ChinaCancer center of SunYat-sen University
Aug 11, 2023
Solid Tumor Trial in Tianjin (Pemigatinib)
Completed
- Solid Tumor
- Pemigatinib
-
Tianjin, ChinaCancer Hospital of Tianjin Medical University
Jul 22, 2021
Advanced Non Small Cell Lung Cancer Trial (Sintilimab, Pemigatinib)
Not yet recruiting
- Advanced Non Small Cell Lung Cancer
- Sintilimab
- Pemigatinib
- (no location specified)
Aug 6, 2021
MPN (Myeloproliferative Tumors) Trial in Worldwide (Pemigatinib)
Active, not recruiting
- MPN (Myeloproliferative Neoplasms)
- Pemigatinib
-
Phoenix, Arizona
- +32 more
Jun 24, 2022
NSCLC (NSCLC) Trial in Worldwide (Pemigatinib)
Recruiting
- Non-Small Cell Lung Cancer (NSCLC)
- Pemigatinib
-
Los Angeles, California
- +41 more
Jun 27, 2022
Cholangiocarcinoma Trial in Worldwide (Pemigatinib)
Completed
- Cholangiocarcinoma
- Pemigatinib
-
Anchorage, Alaska
- +119 more
Apr 4, 2022
Lung Cancer, Solid Tumor, Gastric Cancer Trial in Denmark, United States (Pemigatinib, Gemcitabine + Cisplatin, Pembrolizumab)
Completed
- Lung Cancer
- +10 more
- Pemigatinib
- +5 more
-
Birmingham, Alabama
- +19 more
Jan 4, 2022
Glioblastoma, Adult-type Diffuse Gliomas Trial in Worldwide (Pemigatinib)
Recruiting
- Glioblastoma
- Adult-type Diffuse Gliomas
- Pemigatinib
-
Beverly Hills, California
- +83 more
Jul 25, 2022
UC (Urothelial Cancer) Trial in Worldwide (pemigatinib)
Completed
- UC (Urothelial Cancer)
- pemigatinib
-
Tucson, Arizona
- +95 more
Feb 28, 2022
Solid Tumor Malignancy Trial in Worldwide (Pemigatinib)
Terminated
- Solid Tumor Malignancy
- Pemigatinib
-
Goodyear, Arizona
- +89 more
Jun 14, 2022
Solid Tumors Trial in Japan (Pemigatinib)
Completed
- Solid Tumors
- Pemigatinib
-
Aichi, Japan
- +11 more
May 27, 2020